Literature DB >> 27956053

Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.

Jee-Eun Yoon1, Jun-Sang Sunwoo1, Ji Sun Kim1, Hakjae Roh1, Moo-Young Ahn1, Hee-Yeon Woo2, Kyung Bok Lee3.   

Abstract

BACKGROUND AND
PURPOSE: The association between blood glucose fluctuation and poststroke cardiovascular outcome has been largely unknown. This study attempted to evaluate whether initial glycemic variability increases cardiovascular events and mortality in diabetic patients with acute ischemic stroke.
METHODS: We recruited consecutive patients with acute ischemic stroke or transient ischemic attack from March 2005 to December 2014. A total of 674 patients with diabetes within 72 hours from stroke onset were included. The serum glucose levels were checked 4 times per day during the initial 3 hospital days. J-index, coefficients of variation and standard deviation were calculated for glycemic variability. Composite outcome (nonfatal stroke, nonfatal myocardial infarction, cardiovascular death) and all-cause mortality at 3 months were prospectively captured. Multivariable logistic regression analyses were done adjusting for covariates which can influence on cardiovascular outcomes.
RESULTS: Cardiovascular composite outcomes at 3 months were identified in 71 (10.5%): 11 (6.5%), 15 (8.9%), 18 (10.7%) and 27 (16.0%) in each J-index quartiles (P = .035). The highest quartile of J-index had significantly higher cardiovascular death (4.2%, 3.6%, 6.5% and 11.8%; P = .008). In multivariable logistic regression, age (odds ratio [OR] 1.045; 95% confidence interval [CI] 1.006-1.084), P = .021), NIH stroke scale (OR 1.078; 95% CI 1.024-1.134, P = .004), and the highest J-index (OR 12.058; 95% 1.890-76.912, P = .008) were significantly associated with 3-month cardiovascular composite outcome. Increased cardiovascular outcomes in highest J-index quartile were similar in both euglycemic and hyperglycemic groups.
CONCLUSION: The initial glycemic variability might increase cardiovascular events in acute ischemic stroke patients with diabetes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Cardiovascular outcomes; Glycemic variability; J-index

Mesh:

Substances:

Year:  2016        PMID: 27956053     DOI: 10.1016/j.jdiacomp.2016.11.014

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  15 in total

1.  Poor sleep quality is associated with nocturnal glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetes.

Authors:  Pamela Martyn-Nemeth; Shane A Phillips; Dan Mihailescu; Sarah S Farabi; Chang Park; Rebecca Lipton; Esema Idemudia; Laurie Quinn
Journal:  J Adv Nurs       Date:  2018-07-19       Impact factor: 3.187

Review 2.  Inpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD.

Authors:  Estelle Everett; Nestoras Mathioudakis
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

3.  The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke.

Authors:  Jiaojie Hui; Jianping Zhang; Xuqiang Mao; Zaiwang Li; Xinxin Li; Fengyun Wang; Tao Wang; Qingfang Yuan; Sunwei Wang; Mengjia Pu; Guangjun Xi
Journal:  Neurol Sci       Date:  2018-06-05       Impact factor: 3.307

4.  Acute glycemic variability and mortality of patients with acute stroke: a meta-analysis.

Authors:  Jinbo Lin; Chunsheng Cai; Yituan Xie; Li Yi
Journal:  Diabetol Metab Syndr       Date:  2022-05-10       Impact factor: 5.395

5.  The impact of dapagliflozin on glucose excursions related to early proatherogenic derangement in the aortic wall.

Authors:  Agnieszka Stelmaszyk; Anna Wesołowska; Karolina Pomieczyńska; Saule Iskakova; Magdalena Frydrychowicz; Grzegorz Dworacki; Marzena Dworacka
Journal:  Saudi Pharm J       Date:  2018-07-20       Impact factor: 4.330

6.  Hypoglycaemic treatment adherence and the association with psychological, self-management and glycaemic characteristics in adults with type 1 diabetes.

Authors:  Pamela Martyn-Nemeth; Reid Birlingmair; Esema Idemudia; Chang Park
Journal:  Nurs Open       Date:  2019-03-20

Review 7.  Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.

Authors:  Emma G Wilmot; Pratik Choudhary; Lalantha Leelarathna; Mike Baxter
Journal:  Diabetes Obes Metab       Date:  2019-08-26       Impact factor: 6.577

Review 8.  Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications.

Authors:  Zhen-Ye Zhang; Ling-Feng Miao; Ling-Ling Qian; Ning Wang; Miao-Miao Qi; Yu-Min Zhang; Shi-Peng Dang; Ying Wu; Ru-Xing Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

9.  Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction.

Authors:  Qingqing Lou; Xiaodan Yuan; Shujie Hao; Joshua D Miller; Juan Yan; Panpan Zuo; Jianing Li; Lihong Yang; Hong Li
Journal:  J Diabetes Res       Date:  2020-01-28       Impact factor: 4.011

10.  A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.

Authors:  Pamela Martyn-Nemeth; Jennifer Duffecy; Laurie Quinn; Chang Park; Dan Mihailescu; Sue Penckofer
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.